You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

5 2 chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
  • (no location specified)
Oct 16, 2023

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

Breast Cancer Trial in Toronto (ICG guided sentinel lymph node biopsy)

Recruiting
  • Breast Cancer
  • ICG guided sentinel lymph node biopsy
  • Toronto, Ontario, Canada
    University Health Network
Oct 13, 2023

Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,

Recruiting
  • Gastric Adenocarcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 20, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (STAT

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • STAT Inhibitor OPB-111077
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Dec 20, 2022

POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)

Terminated
  • POLE Exonuclease Mutant Colon Cancer
  • +2 more
  • Sutton, Surrey, United Kingdom
    Royal Marsden NHS Foundation Trust
Oct 5, 2022

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III

Recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +10 more
  • Biopsy
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 20, 2023

Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • +3 more
  • Bevacizumab
  • +11 more
  • (no location specified)
May 9, 2023

Non-squamous Non-small-cell Lung Cancer Trial in Hangzhou (Tusamitamab ravtansine+Sintilimab+Carboplatin or

Not yet recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • Tusamitamab ravtansine+Sintilimab+Carboplatin or Cisplatin+Pemetrexed
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 5, 2023

Rectal Cancer Trial in Detroit (Standard of care chemo with the change for avoidance of extensive surgery)

Recruiting
  • Rectal Cancer
  • Standard of care chemotherapy with the change for avoidance of extensive surgery
  • Detroit, Michigan
    Ascension St. John Hospital
Jan 30, 2023

NSCLC Trial in Canada (Osimertinib First-Line, Platinum + Pemetrexed Chemotherapy Second-Line, Osimertinib Third-Line)

Recruiting
  • Non-Small Cell Lung Cancer
  • Osimertinib First-Line
  • +2 more
  • Vancouver, British Columbia, Canada
  • +9 more
Jun 21, 2022

Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal

Recruiting
  • Cervical Esophagus Adenocarcinoma
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Gynecologic Oncology Patients

Not yet recruiting
  • Gynecologic Cancer
  • +2 more
  • Clinical Frailty Scale
  • Frailty Phenotype
  • Hamilton, Ontario, Canada
  • +2 more
Feb 10, 2023

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

Not yet recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • Locally Advanced Pancreatic Ductal Adenocarcinoma
  • Biospecimen Collection
  • +9 more
  • Los Angeles, California
    Yonemoto,Lisa
Jan 13, 2023

Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Hangzhou (Serplulimab, Albumin paclitaxel, carboplatin AUC=5,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Therapy
  • Serplulimab, Albumin paclitaxel, carboplatin AUC=5, neoadjuvant therapy
  • Esophagectomy
  • Hangzhou, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 20, 2022

Multiple Myeloma, Lymphoma Trial in China (Etoposide, Cyclophosphamide, Mecapegfilgrastim, day 2)

Recruiting
  • Multiple Myeloma
  • Lymphoma
  • Hefei, Anhui, China
  • +6 more
Dec 1, 2022

Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    Northwestern University
Feb 16, 2023

Acute Myeloid Leukemia Trial in Lanzhou (Venetoclax, Azacitidine, Cladribine)

Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    Long Zhao
Apr 24, 2022

Triple Negative Breast Cancer Trial in Guangzhou (Gemcitabine and carboplatin plus antibiotic (moxifloxacin), Gemcitabine

Recruiting
  • Triple Negative Breast Cancer
  • Gemcitabine and carboplatin plus antibiotic (moxifloxacin)
  • Gemcitabine combined with carboplatin plus placebo
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 6, 2022

Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Mouth Neoplasms
  • Carcinoma, Squamous Cell
  • TPF group
  • +2 more
  • Shanghai, Shanghai, China
    Ninth People's Hospital, Shanghai Jiao Tong University School of
Oct 5, 2022

Locally Advanced Rectal Carcinoma Trial (Short course radiotherapy with concurrent capecitabine(825mg/m2), Long course

Not yet recruiting
  • Locally Advanced Rectal Carcinoma
  • Short course radiotherapy with concurrent capecitabine(825mg/m2)
  • Long course radiotherapy with concurrent capecitabine(825mg/m2)
  • (no location specified)
Jun 24, 2023

Tumors, NSCLC Trial (Epacadostat 25 mg, Epacadostat 100 mg, pembrolizumab 200 mg)

Completed
Has Results
  • Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Epacadostat 25 mg
  • +7 more
  • (no location specified)
Aug 17, 2022

Implementation of Personalized Medicine for Optimal Drug Therapy

Not yet recruiting
  • Nausea With Vomiting Chemotherapy-Induced
  • +2 more
  • Pharmacogenetic testing
  • Drug-Drug interaction analysis
  • London, Ontario, Canada
    Lawson Health Research Institute
Apr 13, 2023